hovedpine, for højt blodtryk, trombose (blodpropper), smerte på injektionsstedet, ledsmerter og væskeansamling i lemmerne.
au patients with kidney disease, and at keeping these levels maintained after they had been improved, whether given as an intravenous or subcutaneous injection.